Cellectar Biosciences, Inc.

NasdaqCM:CLRB Stock Report

Market Cap: US$10.5m

Cellectar Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CLRB?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,188,0032.88%
Hedge Funds2,712,4436.57%
VC/PE Firms3,197,3947.75%
Institutions8,949,94021.7%
General Public25,222,05061.1%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 235.8%.

Top Shareholders

Top 25 shareholders own 38.45% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.9%
Rosalind Advisors, Inc.
3,671,550US$930.7k35.7%0.54%
7.75%
Aigh Capital Management, LLC
3,197,394US$810.5k5.31%0.33%
6.57%
Nantahala Capital Management, LLC
2,712,443US$687.6k48%0.05%
4.18%
The Vanguard Group, Inc.
1,726,986US$437.8k10.4%no data
2.27%
Laurence Lytton
937,728US$237.7k4.47%no data
2.25%
ADAR1 Capital Management, LLC
929,096US$235.5k36.2%0.04%
2.05%
Lincoln Park Capital, LLC
847,647US$214.9k0%11.44%
0.85%
Geode Capital Management, LLC
352,452US$89.3k3.3%no data
0.56%
BlackRock, Inc.
232,320US$58.9k1.48%no data
0.52%
Altium Capital Management LP
215,000US$54.5k0%0.02%
0.4%
Bank of America Corporation, Asset Management Arm
164,449US$41.7k163%no data
0.34%
Morgan Stanley, Investment Banking and Brokerage Investments
139,231US$35.3k66.9%no data
0.29%
Barclays Bank PLC, Securities Investments
120,497US$30.5k-30%no data
0.28%
State Street Global Advisors, Inc.
116,814US$29.6k0%no data
0.15%
Northern Trust Global Investments
61,094US$15.5k0%no data
0.14%
Man Group Plc
56,000US$14.2k0%no data
0.13%
Andrei Shustov
55,038US$14.0k0%no data
0.13%
Jarrod Longcor
53,141US$13.5k0%no data
0.13%
XTX Holdings Limited, Asset Management Arm
53,022US$13.4k-16.2%no data
0.12%
James Caruso
49,218US$12.5k0%no data
0.1%
Chad Kolean
42,578US$10.8k0%no data
0.096%
Darrell Lea
39,599US$10.0k0%no data
0.096%
Spearhead Insurance Solutions Idf, Llc
39,553US$10.0k0%0.49%
0.073%
Raymond James Financial Services Advisors, Inc.
30,000US$7.6k0%no data
0.061%
Pale Fire Capital SE
25,030US$6.3k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 15:28
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Cellectar Biosciences, Inc. is covered by 11 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kumaraguru RajaBrookline Capital Markets
Keith MarkeyGriffin Securities
Swayampakula RamakanthH.C. Wainwright & Co.